Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

330.31 +6.17 (+1.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	707,193
Open	324.14
Bid (Size)	325.11 (600)
Ask (Size)	333.00 (100)
Prev. Close	324.14
Today's Range	321.19 - 331.88
52wk Range	157.43 - 343.18
Shares Outstanding	139,693,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Reasons Investors Love Natera (NTRA)

Today 0:02 EDT

What a time it’s been for Natera. In the past six months alone, the company’s stock price has increased by a massive 59.9%, reaching $328.13 per share. This ...

Via StockStory

Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia) ↗

September 08, 2026

His largest position today is a bet on genomics.

Via The Motley Fool

Performance

YTD	+44.3%	+44.3%
1 Month	+3.8%	+3.8%
3 Month	+48.2%	+48.2%
6 Month	+66.0%	+66.0%
1 Year	+97.3%	+97.3%

More News

Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗

September 04, 2026

Via Benzinga

New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma

September 01, 2026

From Natera, Inc.

Via Business Wire

3 Momentum Stocks to Own for Decades

August 31, 2026

Via StockStory

Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run? ↗

August 29, 2026

Via The Motley Fool

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer

August 28, 2026

From Natera, Inc.

Via Business Wire

Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™

August 27, 2026

From Natera, Inc.

Via Business Wire

3 Healthcare Stocks with Promising Prospects

August 27, 2026

Via StockStory

Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal ↗

August 26, 2026

Via The Motley Fool

Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either. ↗

August 24, 2026

Via The Motley Fool

3 Large-Cap Stocks Worth Investigating

August 24, 2026

Via StockStory

2 Biotech Stocks Shaping Up for Major Breakouts ↗

August 22, 2026

Via MarketBeat

Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? ↗

August 20, 2026

Via The Motley Fool

Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today ↗

August 18, 2026

Via Benzinga

Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks

August 17, 2026

Via StockStory

Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference ↗

August 15, 2026

Via MarketBeat

Natera (NTRA) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Via The Motley Fool

5 Insightful Analyst Questions From Natera’s Q2 Earnings Call

August 13, 2026

Via StockStory

Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers

August 12, 2026

From Natera, Inc.

Via Business Wire

What to Know About This Natera Insider Transaction as Shares Surge to Record Highs ↗

August 10, 2026

Via The Motley Fool

A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests ↗

August 10, 2026

Via The Motley Fool

Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know ↗

August 10, 2026

Via The Motley Fool

A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It ↗

August 10, 2026

Via The Motley Fool

A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know ↗

August 10, 2026

Via The Motley Fool

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?

Yes, Natera, Inc. - Common Stock is publicly traded.

What exchange does Natera, Inc. - Common Stock trade on?

Natera, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Natera, Inc. - Common Stock?

The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market

What is the current price of Natera, Inc. - Common Stock?

The current price of Natera, Inc. - Common Stock is 330.31

When was Natera, Inc. - Common Stock last traded?

The last trade of Natera, Inc. - Common Stock was at 09/09/26 04:00 PM ET

What is the market capitalization of Natera, Inc. - Common Stock?

The market capitalization of Natera, Inc. - Common Stock is 46.14B

How many shares of Natera, Inc. - Common Stock are outstanding?

Natera, Inc. - Common Stock has 46B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.